Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database

Richard LeBlanc, Hira Mian, Donna Reece, Esther Masih-Khan, Moustafa Kardjadj, Victor H. Jimenez-Zepeda, Arleigh McCurdy, Kevin Song, Michael Sebag, Martha Louzada, Darrell White, Julie Stakiw, Rami Kotb, Anthony Reiman, Muhammad Aslam, Engin Gul, Christopher P. Venner

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)93-102
Number of pages10
JournalBritish Journal of Haematology
Volume198
Issue number1
DOIs
Publication statusPublished - Jul 2022

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • daratumumab
  • multiple myeloma
  • real-world data

Fingerprint

Dive into the research topics of 'Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database'. Together they form a unique fingerprint.

Cite this

LeBlanc, R., Mian, H., Reece, D., Masih-Khan, E., Kardjadj, M., Jimenez-Zepeda, V. H., McCurdy, A., Song, K., Sebag, M., Louzada, M., White, D., Stakiw, J., Kotb, R., Reiman, A., Aslam, M., Gul, E., & Venner, C. P. (2022). Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database. British Journal of Haematology, 198(1), 93-102. https://doi.org/10.1111/bjh.18172